Efficacy of Suprascapular Radiofrequency Ablation in Hemiplegic Shoulder Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorYunus Burak Bayır

About this trial

Stroke, one of the most important causes of disability and death in the world, is an acute focal deficit of the central system caused by vascular origin such as cerebral infarction, intracerebral haemorrhage and subarachnoid haemorrhage. Hemiplegic shoulder pain, which is one of the most common complications after stroke, is an important problem affecting extremity rehabilitation. Although there are many factors thought to cause haemiplegic shoulder pain, there is still controversy about its treatment. Although there are many treatment strategies for this complication such as analgesics, antispasmotics, local corticosteroid injections, suprascapular nerve blockade, physical therapy modalities and exercise therapy, sometimes very resistant cases are also seen. For the treatment of persistent haemiplegic shoulder pain unresponsive to conventional treatment modalities, intra-articular injection of corticosteroids into the shoulder joint is commonly used, but its palliative effect has only a relatively short duration.Corticosteroids may also have adverse effects such as allergic reactions, rash, hyperglycaemia, menstrual disorders and adrenal suppression. Suprascapular nerve block is another option to relieve haemiplegic shoulder pain. The suprascapular nerve provides 70% of the sensory innervation of the shoulder joint. Thus, blocking pain transmission through the SS provides effective control of haemiplegic shoulder pain. However, the efficacy of suprascapular nerve block varies according to the study population and depends on the therapeutic modality to which it is compared. In addition, the effect of suprascapular nerve blockade may be limited due to the short duration of action of local anaesthetic agents. Neurolysis may cause permanent paralysis of the supraspinatus and infraspinatus muscles. For this reason, a deconstructive method is not preferred. Pulse RF applications, which is a non-deconstructive, neuromodulatory method, may be preferred in this regard. So far, there are very few studies investigating the efficacy of intra-articular steroid injection, suprascapular block and pulse RF in hemiplegic shoulder pain separately, but there is no study investigating the efficacy of Pulse RF treatment against other treatment methods together. In this study, investigator's aim was to compare the efficacy of suprascapular pulse radiofrequency against USG-guided suprascapular nerve block and intra-articular steroid injections in hemiplegic shoulder pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being over 18 years old

Those who were diagnosed with hemorrhagic or ischemic stroke at least 3 months ago

Patients with shoulder pain with VAS > 5 severity after hemiplegia

Those who agree to participate with a consent document (their own or their foster family)

Disqualifiers

Those who did not provide a consent document

Those under 18 years of age

Those who cannot cooperate

Severely aphasic patients

Trial design

Design model

Parallel

Treatments tested in this trial

  • Suprascapular nerve pulse radiofrequency ablation

    Procedure/Surgery

    Pulse RF application will be applied to the suprascapular nerve once under US guidance with a TOP-TLG10 STP generator at a maximum temperature of 42 degrees, 2 Hz, 20 ms and 45 V for 2 minutes.

  • Suprascapular Nerve Block Group

    Procedure/Surgery

    Suprascapular block will be applied once with a mixture consisting of 5 ml (1 ml betamethasone, 2% lidocaine 2 ml, 0.9% saline 2 ml).

  • Steroid Group

    Procedure/Surgery

    Intra-articular steroid application will be made with a mixture consisting of 5 ml (2 ml of 2% lidocaine, 2 ml of 0.9% saline and 1 ml of betamethasone 5 mg).

Treatment groups

84 Participants
are divided into 3 treatment groups
Group A: Pulse Radiofrequency AblationActive comparator 1 intervention
Group B: Suprascapular Nerve Block InjectionActive comparator 1 intervention
Group C: Intra-articular Steroid İnjectionActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Visual Analog Scale (VAS)

Shoulder pain.The VAS used for pain assessment consists of a line drawn in the form of a ruler, and numbers from 0 to 10 (with 0 as "no pain" and 10 as "unbearable pain") were asked to score.

Time frame
This evaluation will be made and recorded at the beginning, at the 1st, 4th and 12th weeks after the procedure.
2

painful angle of the shoulder

painful angle of the shoulder

Time frame
This evaluation will be made and recorded at the beginning, at the 1st, 4th and 12th weeks after the procedure.

Secondary outcomes

1

range of motion

range of motion (ROM; flexion, abduction, internal and external rotation)

Time frame
This evaluation will be made and recorded at the beginning, at the 1st, 4th and 12th weeks after the procedure.
2

Goal Attainment Scale (GAS)

Goal Attainment Scale (GAS) during upper-body dressingIn the functional evaluation, the GAS during upper-body dressing was used to assess the effect of shoulder pain on functional capacity. GAS is a mathematical tech- nique for quantifying the achievement (or otherwise) of goals set, and it can be used in rehabilitation (7). According to this scale, pain during upper extremity dressing was evaluated (-2: severe pain, -1: moderate pain, 0: mild pain, +1: pain at the end of movement, and +2: painless motion. The highest indicating the best score.

Time frame
This evaluation will be made and recorded at the beginning, at the 1st, 4th and 12th weeks after the procedure.
3

Modified Barthel Index

Physical competence and independence in daily living activities will be evaluatedIn the modified Barthel index, the level of functional independence in a total of 10 activities such as transfer, movement, stairs, nutrition, dressing, personal care, bathing, sitting and rising to the toilet, urinary and faecal incontinence is evaluated. The total score varies between 0-100. Zero score indicates complete dependence and 100 score indicates complete independence.

Time frame
This evaluation will be made and recorded at the beginning, at the 1st, 4th and 12th weeks after the procedure.
4

SPADI

Shoulder Pain and Disability Index scoreIt is a 13-item questionnaire categorised into pain and activity limitation. The score ranges from 0-100.The highest indicating the best score.

Time frame
This evaluation will be made and recorded at the beginning, at the 1st, 4th and 12th weeks after the procedure.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Yunus Burak Bayır

Lead sponsor

Ankara Etlik City Hospital

Sponsor institution